These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7487335)

  • 1. Cyclodextrins for growth of Helicobacter pylori and production of vacuolating cytotoxin.
    Marchini A; d'Apolito M; Massari P; Atzeni M; Copass M; Olivieri R
    Arch Microbiol; 1995 Oct; 164(4):290-3. PubMed ID: 7487335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimized conditions for the fermentation of Helicobacter pylori and production of vacuolating cytotoxin.
    Marchini A; Massari P; Manetti R; Olivieri R
    FEMS Microbiol Lett; 1994 Nov; 124(1):55-9. PubMed ID: 8001770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between vacuolating cytotoxin production by Helicobacter pylori isolates in vitro and in vivo.
    Cover TL; Cao P; Lind CD; Tham KT; Blaser MJ
    Infect Immun; 1993 Dec; 61(12):5008-12. PubMed ID: 8225576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth medium containing cyclodextrin and low concentration of horse serum for cultivation of Helicobacter pylori.
    Morshed MG; Karita M; Konishi H; Okita K; Nakazawa T
    Microbiol Immunol; 1994; 38(11):897-900. PubMed ID: 7898389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vacuolating cytotoxin production by Helicobacter pylori isolates from peptic ulcer, atrophic gastritis and gastric carcinoma patients.
    Murakita H; Hirai M; Ito S; Azuma T; Kato T; Kohli Y
    Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S29-31. PubMed ID: 7735931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative evaluation of three supplements for Helicobacter pylori growth in liquid culture.
    Douraghi M; Kashani SS; Zeraati H; Esmaili M; Oghalaie A; Mohammadi M
    Curr Microbiol; 2010 Apr; 60(4):254-62. PubMed ID: 19949795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cholesterol on Helicobacter pylori growth and virulence properties in vitro.
    Jiménez-Soto LF; Rohrer S; Jain U; Ertl C; Sewald X; Haas R
    Helicobacter; 2012 Apr; 17(2):133-9. PubMed ID: 22404444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro cytotoxic effects of vacuolating cytotoxin produced by clinical isolates of Helicobacter pylori.
    Kodama K; Fujioka T; Ito A; Nishizono A; Nasu M
    Kansenshogaku Zasshi; 1998 Oct; 72(10):1027-34. PubMed ID: 9847519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical detection of Helicobacter pylori vacuolating cytotoxin in the hepatocytes of patients with isolated hypertransaminasaemia.
    Francavilla A; Ierardi E; Francavilla R; Principi M; Gentile A; Margiotta M; Balzano T; Passaro S; Noviello F; Panella C; Pollice L
    Ital J Gastroenterol Hepatol; 1999 Nov; 31(8):669-74. PubMed ID: 10730557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of monoclonal antibodies neutralizing vacuolation of cultured cells by Helicobacter pylori cytotoxin.
    Yamaguchi H; Osaki T; Taguchi H; Kamiya S
    FEMS Microbiol Lett; 1998 Nov; 168(2):277-82. PubMed ID: 9835039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoskeletal rearrangements induced by Helicobacter pylori strains in epithelial cell culture: possible role of the cytotoxin.
    Ashorn M; Cantet F; Mayo K; Megraud F
    Dig Dis Sci; 2000 Sep; 45(9):1774-80. PubMed ID: 11052319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth of Helicobacter pylori in media containing cyclodextrins.
    Olivieri R; Bugnoli M; Armellini D; Bianciardi S; Rappuoli R; Bayeli PF; Abate L; Esposito E; de Gregorio L; Aziz J
    J Clin Microbiol; 1993 Jan; 31(1):160-2. PubMed ID: 8417026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of correlation between vacuolating cytotoxin activity, cagA gene in Helicobacter pylori, and peptic ulcer disease in children.
    Loeb M; Jayaratne P; Jones N; Sihoe A; Sherman P
    Eur J Clin Microbiol Infect Dis; 1998 Sep; 17(9):653-6. PubMed ID: 9832269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of peptic ulcer with increased expression of Lewis antigens, but not vacuolating cytotoxin activity or babA2 gene status, in Helicobacter pylori strains from China.
    Zheng PY; Tang FA; Qi YM; Li J
    Chin J Dig Dis; 2006; 7(1):61-5. PubMed ID: 16412040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of medium composition on the growth and antigen expression of Helicobacter pylori.
    Walsh EJ; Moran AP
    J Appl Microbiol; 1997 Jul; 83(1):67-75. PubMed ID: 9246772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A thin-layer liquid culture technique for the growth of Helicobacter pylori.
    Joo JS; Park KC; Song JY; Kim DH; Lee KJ; Kwon YC; Kim JM; Kim KM; Youn HS; Kang HL; Baik SC; Lee WK; Cho MJ; Rhee KH
    Helicobacter; 2010 Aug; 15(4):295-302. PubMed ID: 20633190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic analysis of the Helicobacter pylori vacuolating cytotoxin: structural similarities with the IgA protease type of exported protein.
    Schmitt W; Haas R
    Mol Microbiol; 1994 Apr; 12(2):307-19. PubMed ID: 8057855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of a cytotoxin by Helicobacter pylori.
    Leunk RD
    Rev Infect Dis; 1991; 13 Suppl 8():S686-9. PubMed ID: 1925309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of vacuolating cytotoxin in clinical isolates of Helicobacter pylori.
    Kodama K; Fujioka T; Ito A; Kubota T; Murakami K; Nasu M
    J Gastroenterol; 1996 Nov; 31 Suppl 9():9-11. PubMed ID: 8959510
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neutralisation of vacuolating activity of cytotoxin by serum antibodies of Helicobacter pylori infected patients.
    Gościniak G; Przondo-Mordarska A; Iwańczak B; Poniewierka E
    Acta Microbiol Pol; 2000; 49(2):113-20. PubMed ID: 11093674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.